Abstract
Abstract
Background: Pregnancy related gastric cancer is characterised by refractory nature and poor prognosis, few gastric cancer cases during pregnancy achieved acceptable outcomes by using anti-PD-1 as a monotherapy.
Case presentation: A 32-year-old female patient was admitted to the emergency department of obstetrics and gynaecology department, and eventually diagnosed with gastric cancer. Radical surgery for gastric cancer was conducted after termination of pregnancy. One year postoperative follow-up exerted tumour recurrence, this patient has achieved promising results after receiving anti-PD-1 as a monotherapy.
Conclusions: Some specific pregnancy related gastric cancer patients may benefit significantly from immunotherapy.
Publisher
Research Square Platform LLC
Reference22 articles.
1. Dragos Predescu. Pregnancy and Gastric Cancer: A Narrative Review;Adrian Constantin R;Diagnostics (Basel),2023
2. Management of patients with pregnancy-associated gastric cancer in Japan: a mini-review;Kaoru Sakamoto T;Int J Clin Oncol,2009
3. Clinical characteristics of gastric cancer associated with pregnancy;Lee H-J;Dig Surg,2009
4. Tanda ET, Croce E, Spagnolo F, Zullo L, Spinaci S, Genova C, Giovanni Rossi. Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors? Front Oncol. 2021;11:736123. 10.3389/fonc.2021.736123. eCollection 2021.
5. Freddie Bray. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Hyuna Sung J;CA Cancer J Clin,2021